Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02092233 · ClinicalTrials.gov registry record
A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients
A clinical trial, sponsored by Luminex Corporation.
- Completed
- Registry status
- 1,963
- Enrollment target
NCT02092233 is a clinical trial that has completed, run by Luminex Corporation. The registered enrollment target is 1,963 participants.
The verdict
NCT02092233 has completed, sponsored by Luminex Corporation.
- COMPLETED
- Registry status
- 1,963 participants
- Enrollment target
Study Summary
The ARIES HSV 1\&2 Assay is a PCR based test for the direct detection and typing of herpes simplex virus (HSV 1 \& 2) DNA. The objective is to establish the diagnostic accuracy of ARIES HSV-1\&2 Assay.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,963 participants |
| Start Date | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02092233
The ClinicalTrials.gov registry entry for NCT02092233 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,963 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Luminex Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02092233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02092233 about?
NCT02092233 is a clinical study titled "A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients". The ARIES HSV 1\&2 Assay is a PCR based test for the direct detection and typing of herpes simplex virus (HSV 1 \& 2) DNA. The objective is to establish the diagnostic accuracy of ARIES HSV-1\&2 Assay.
What is the current status of trial NCT02092233?
This trial is currently completed. The enrollment target is 1,963 participants. The study started on 2014-01.
Who is sponsoring clinical trial NCT02092233?
This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.